Most SM patients (∼94%) show morphologically abnormal CD25+ BM MCs [2, 3] that carry KIT mutations [4–7], from which the KIT D816V is the most common one (∼90% of SM cases) [6]. This evidence concerns the gene KIT and systemic mastocytosis.